Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish V Joshi

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Journal of Medical Economics|April 10, 2013
Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial populationMargarita Udall, Anthony Louder, Brandon T Suehs, et al.
The American Surgeon|January 12, 2008
Excess mortality, length of stay, and costs associated with serious hemorrhage among trauma patients: findings from the National Trauma Data BankLuke Boulanger, Ashish V Joshi, Bartholomew J Tortella, et al.
BMC Psychiatry|December 14, 2011
Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort studyAriel Berger, John Edelsberg, Vamsi Bollu, et al.
Journal of Comparative Effectiveness Research|August 18, 2017
Real-world comparison of treatment patterns and effectiveness of albiglutide and liraglutideErin K Buysman, Mirko V Sikirica, Sarah W Thayer, et al.
Infectious Diseases and Therapy|June 13, 2024
Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort StudyAxel Krinner, Michael Schultze, Alen Marijam, et al.
Current Medical Research and Opinion|February 1, 2008
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modelingRahul D Ballal, Marc F Botteman, Isaac Foley, et al.
The American Journal of Managed Care|June 22, 2010
Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plansJay M Margolis, Zhun Cao, Eberechukwu Onukwugha, et al.
Journal of Medical Economics|July 23, 2009
Burden of blood transfusion in knee and hip surgery in the US and BelgiumChristopher M Blanchette, Ashish V Joshi, Marek Szpalski, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 26, 2013
Cost drivers of prescription opioid abuse in commercial and Medicare populationsMargaret K Pasquale, Ashish V Joshi, Robert Dufour, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 12, 2011
Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of careNathan L Kleinman, Robert J Sanchez, Wendy D Lynch, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Journal of Medical Economics|April 10, 2013
Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial populationMargarita Udall, Anthony Louder, Brandon T Suehs, et al.
The American Surgeon|January 12, 2008
Excess mortality, length of stay, and costs associated with serious hemorrhage among trauma patients: findings from the National Trauma Data BankLuke Boulanger, Ashish V Joshi, Bartholomew J Tortella, et al.
BMC Psychiatry|December 14, 2011
Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort studyAriel Berger, John Edelsberg, Vamsi Bollu, et al.
Journal of Comparative Effectiveness Research|August 18, 2017
Real-world comparison of treatment patterns and effectiveness of albiglutide and liraglutideErin K Buysman, Mirko V Sikirica, Sarah W Thayer, et al.
Infectious Diseases and Therapy|June 13, 2024
Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort StudyAxel Krinner, Michael Schultze, Alen Marijam, et al.
Current Medical Research and Opinion|February 1, 2008
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modelingRahul D Ballal, Marc F Botteman, Isaac Foley, et al.
The American Journal of Managed Care|June 22, 2010
Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plansJay M Margolis, Zhun Cao, Eberechukwu Onukwugha, et al.
Journal of Medical Economics|July 23, 2009
Burden of blood transfusion in knee and hip surgery in the US and BelgiumChristopher M Blanchette, Ashish V Joshi, Marek Szpalski, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 26, 2013
Cost drivers of prescription opioid abuse in commercial and Medicare populationsMargaret K Pasquale, Ashish V Joshi, Robert Dufour, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 12, 2011
Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of careNathan L Kleinman, Robert J Sanchez, Wendy D Lynch, et al.
Pageof 8